Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Inv. presentation
Cert. of designation
Quarterly results
Acq. announced
|
|
HARROW HEALTH, INC. (IMMY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/20/2023 |
SC 13G/A
| Opaleye Management Inc. reports a 12.8% stake in HARROW HEALTH, INC. |
| 02/10/2022 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 4.5% stake in Harrow Health, Inc. |
| 01/25/2022 |
SC 13G/A
| Opaleye Management Inc. reports a 12.2% stake in HARROW HEALTH, INC. |
| 07/12/2021 |
SC 13G/A
| BlackRock Inc. reports a 1.6% stake in HARROW HEALTH INC |
| 02/12/2021 |
SC 13G/A
| Opaleye Management Inc. reports a 11.9% stake in HARROW HEALTH, INC. |
| 05/26/2020 |
SC 13G/A
| Opaleye Management Inc. reports a 10.3% stake in HARROW HEALTH, INC. |
| 02/14/2020 |
SC 13G/A
| Opaleye Management Inc. reports a 9.3% stake in HARROW HEALTH, INC. |
| 02/14/2019 |
SC 13G/A
| Opaleye Management Inc. reports a 7.4% stake in HARROW HEALTH, INC. |
| 04/19/2017 |
SC 13G/A
| Longboard Capital Advisors, LLC reports a 7.1% stake in Imprimis Pharmaceuticals, Inc. |
| 02/23/2017 |
SC 13G/A
| Opaleye Management Inc. reports a 3.9% stake in Imprimis Pharmaceuticals, Inc. |
| 02/17/2017 |
SC 13G/A
| Perella Weinberg Partners Capital Management LP reports a 0.9% stake in Imprimis Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2016 |
SC 13G/A
| TRANSDEL PHARMACEUTICALS INC reports a 0% stake in Imprimis Pharmaceuticals, Inc. |
| 02/12/2016 |
SC 13G/A
| Opaleye Management Inc. reports a 7.1% stake in Axogen Corp. |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2011 |
SC 13G/A
| TRANSDEL PHARMACEUTICALS INC reports a 9.8% stake in Transdel Pharmaceuticals, Inc. |
| 02/10/2011 |
SC 13G/A
| TRANSDEL PHARMACEUTICALS INC reports a 7.4% stake in Transdel Pharmaceuticals, Inc. |
| 02/10/2011 |
SC 13G/A
| TRANSDEL PHARMACEUTICALS INC reports a 15.5% stake in Transdel Pharmaceuticals, Inc. |
| 02/16/2010 |
SC 13G/A
| TRANSDEL PHARMACEUTICALS INC reports a 10% stake in Transdel Pharmaceuticals, Inc. |
| 02/12/2010 |
SC 13G/A
| TRANSDEL PHARMACEUTICALS INC reports a 14.1% stake in Transdel Pharmaceuticals, Inc. |
| 02/11/2010 |
SC 13G/A
| TRANSDEL PHARMACEUTICALS INC reports a 7.5% stake in Transdel Pharmaceuticals, Inc. |
| 02/13/2009 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2009 |
SC 13G/A
| Abrams Family Trust reports a 10% stake in Transdel Pharmaceuticals, Inc. |
|
|